Industry Research Reports
Part 1
Part 2
Part 3
Part 5
Home > Reports >
Medical Care
>
Global and Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Insights, Forecast to 2028
Global and Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Insights, Forecast to 2028
-
Description
- Table of Contents
- Table of Figures
- PDF Download
-
Description
- Table of Contents
- Table of Figures
- PDF Download
Market Analysis and Insights: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market This report focuses on global and Japan T-Cell & NK-Cell Engaging Bispecific Antibodies market.
In 2021, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was US$ 472 million and it is expected to reach US$ 5072 million by the end of 2028, with a CAGR of 40.82% during 2021-2028. In Japan the T-Cell & NK-Cell Engaging Bispecific Antibodies market size is expected to grow from US$ 1.88 million in 2021 to US$ 173.15 million by 2028, at a CAGR of 99.82% during the forecast period. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Scope and Market Size T-Cell & NK-Cell Engaging Bispecific Antibodies market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global T-Cell & NK-Cell Engaging Bispecific Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2017-2028. By Company Amgen Immunocore Johnson & Johnson Roche Company Five AbbVie MacroGenics Regeneron Astellas Pharma GEMoaB Monoclonals Molecular Partners AstraZeneca Merck Eli Lilly IGM Biosciences Novartis CytomX Therapeutics Lava Therapeutics Takeda Segment by Type T Cell Engagers NK Cell Engagers Segment by Application Hematological Cancers Solid Tumors By Region North America United States Canada Mexico Asia-Pacific China Japan South Korea Southeast Asia Australia India Rest of Asia Europe Germany France U.K. Italy Russia Rest of Europe South America Brazil Rest of South America Middle East & Africa Middle East Africa
1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 2
1.2.2 T Cell Engagers 3
1.2.3 NK Cell Engagers 4
1.3 Market by Application 5
1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application: 2017 VS 2021 VS 2028 5
1.3.2 Hematological Cancers 7
1.3.3 Solid Tumors 7
1.4 Study Objectives 7
1.5 Years Considered 8
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Perspective (2017-2028) 9
2.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Growth Trends by Regions 10
2.2.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Regions: 2017 VS 2021 VS 2028 10
2.2.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Regions (2017-2022) 12
2.2.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Regions (2023-2028) 12
2.2.4 Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share in Global Market 2017-2028 14
2.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Dynamic 14
2.3.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends 14
2.3.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers 15
2.3.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges 16
2.3.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints 16
3.1 Global Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players by Revenue 17
3.1.1 Global Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players by Revenue (2017-2022) 17
3.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Players (2017-2022) 17
3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) 18
3.3 Players Covered: Ranking by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 19
3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Ratio 19
3.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Ratio (CR5 and HHI) 19
3.4.2 Global Top 2 Companies by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2021 20
3.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Players Head office and Area Served 20
3.6 Key Players T-Cell & NK-Cell Engaging Bispecific Antibodies Product Solution and Service 21
3.7 Date of Enter into T-Cell & NK-Cell Engaging Bispecific Antibodies Market 21
3.8 Mergers & Acquisitions, Expansion Plans 22
4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Type (2017-2022) 24
4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Type (2023-2028) 25
5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Application (2017-2022) 26
5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Application (2023-2028) 27
6.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2017-2028) 28
6.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) 28
6.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) 29
6.4 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) 29
6.4.1 United States 30
6.4.2 Canada 31
6.4.3 Mexico 32
7.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2017-2028) 33
7.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) 33
7.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) 34
7.4 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) 34
7.4.1 Germany 36
7.4.2 France 37
7.4.3 U.K. 38
7.4.4 Italy 39
7.4.5 Russia 40
8.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2017-2028) 41
8.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) 41
8.3 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) 42
8.4 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (2017-2022) 42
8.4.1 China 43
8.4.2 Japan 44
8.4.3 South Korea 45
8.4.4 Southeast Asia 45
8.4.5 India 46
9.1 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2017-2028) 47
9.2 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) 47
9.3 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) 48
9.4 South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) 48
9.4.1 Brazil 49
10.1 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2017-2028) 50
10.2 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) 50
10.3 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) 51
10.4 Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) 51
10.4.1 Middle East 52
10.4.2 Africa 53
11.1 Amgen 54
11.1.1 Amgen Company Details 54
11.1.2 Amgen Business Overview 54
11.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 55
11.1.4 Amgen Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies Business (2017-2022) 56
11.1.5 Amgen Recent Development 56
11.2 Immunocore 57
11.2.1 Immunocore Company Details 57
11.2.2 Immunocore Business Overview 58
11.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 58
11.2.4 Immunocore Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies Business (2017-2022) 59
11.2.5 Immunocore Recent Development 59
11.3 Johnson & Johnson 60
11.3.1 Johnson & Johnson Company Details 60
11.3.2 Johnson & Johnson Business Overview 60
11.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 61
11.3.4 Johnson & Johnson Recent Development 62
11.4 Roche 62
11.4.1 Roche Company Details 62
11.4.2 Roche Business Overview 63
11.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 63
11.4.4 Roche Recent Development 64
11.5 Pfizer 65
11.5.1 Pfizer Company Details 65
11.5.2 Pfizer Business Overview 65
11.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 66
11.5.4 Pfizer Recent Development 66
11.6 AbbVie 66
11.6.1 AbbVie Company Details 66
11.6.2 AbbVie Business Overview 67
11.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 67
11.6.4 AbbVie Recent Development 68
11.7 MacroGenics 68
11.7.1 MacroGenics Company Details 68
11.7.2 MacroGenics Business Overview 69
11.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 69
11.7.4 MacroGenics Recent Development 69
11.8 Regeneron 70
11.8.1 Regeneron Company Details 70
11.8.2 Regeneron Business Overview 70
11.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Introduction 70
11.8.4 Regeneron Recent Development 71
11.9 Astellas Pharma 71
11.9.1 Astellas Pharma Company Details 71
11.9.2 Astellas Pharma Business Overview 71
11.9.3 Astellas Pharma Recent Development 72
11.10 GEMoaB Monoclonals 72
11.10.1 GEMoaB Monoclonals Company Details 72
11.10.2 GEMoaB Monoclonals Business Overview 73
11.10.3 GEMoaB Monoclonals Recent Development 73
11.11 Molecular Partners 74
11.11.1 Molecular Partners Company Details 74
11.11.2 Molecular Partners Business Overview 74
11.11.3 Molecular Partners Recent Development 74
11.12 AstraZeneca 75
11.12.1 AstraZeneca Company Details 75
11.12.2 AstraZeneca Business Overview 75
11.12.3 AstraZeneca Recent Development 76
11.13 Merck 76
11.13.1 Merck Company Details 76
11.13.2 Merck Business Overview 76
11.13.3 Merck Recent Development 77
11.14 Eli Lilly 77
11.14.1 Eli Lilly Company Details 77
11.14.2 Eli Lilly Business Overview 78
11.14.3 Eli Lilly Recent Development 78
11.15 IGM Biosciences 79
11.15.1 IGM Biosciences Company Details 79
11.15.2 IGM Biosciences Business Overview 79
11.15.3 IGM Biosciences Recent Development 80
11.16 Novartis 80
11.16.1 Novartis Company Details 80
11.16.2 Novartis Business Overview 80
11.16.3 Novartis Recent Development 81
11.17 CytomX Therapeutics 81
11.17.1 CytomX Therapeutics Company Details 81
11.17.2 CytomX Therapeutics Business Overview 82
11.17.3 CytomX Therapeutics Recent Development 82
11.18 Lava Therapeutics 83
11.18.1 Lava Therapeutics Company Details 83
11.18.2 Lava Therapeutics Business Overview 83
11.18.3 Lava Therapeutics Recent Development 83
11.19 Takeda 84
11.19.1 Takeda Company Details 84
11.19.2 Takeda Business Overview 84
11.19.3 Takeda Recent Development 84
13.1 Research Methodology 88
13.1.1 Methodology/Research Approach 88
13.1.2 Data Source 91
13.2 Disclaimer 94
Table 1. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 2 Table 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 5 Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Regions (US$ Million): 2017 VS 2021 VS 2028 10 Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Regions (2017-2022) & (US$ Million) 12 Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Regions (2017-2022) 12 Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Regions (2023-2028) & (US$ Million) 12 Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Regions (2023-2028) 13 Table 8. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends 14 Table 9. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers 15 Table 10. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges 16 Table 11. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints 16 Table 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Players (2017-2022) & (US$ Million) 17 Table 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Players (2017-2022) 17 Table 14. Global Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2022) 18 Table 15. Ranking of Global Top T-Cell & NK-Cell Engaging Bispecific Antibodies Companies by Revenue (US$ Million) in 2021 19 Table 16. Global 5 Largest Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (CR5 and HHI) & (2017-2022) 20 Table 17. Key Players Headquarters and Area Served 20 Table 18. Key Players T-Cell & NK-Cell Engaging Bispecific Antibodies Product Solution and Service 21 Table 19. Date of Enter into T-Cell & NK-Cell Engaging Bispecific Antibodies Market 21 Table 20. Mergers & Acquisitions, Expansion Plans 22 Table 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 24 Table 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2017-2022) 24 Table 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Type (2023-2028) & (US$ Million) 25 Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2023-2028) 25 Table 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 26 Table 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2017-2022) 26 Table 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Application (2023-2028) & (US$ Million) 27 Table 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2023-2028) 27 Table 29. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 28 Table 30. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type (2017-2022) 29 Table 31. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 29 Table 32. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application (2017-2022) 29 Table 33. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) & (US$ Million) 29 Table 34. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Country (2017-2022) 30 Table 35. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 33 Table 36. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type (2017-2022) 34 Table 37. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 34 Table 38. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application (2017-2022) 34 Table 39. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) & (US$ Million) 34 Table 40. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Country (2017-2022) 35 Table 41. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 41 Table 42. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type (2017-2022) 42 Table 43. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 42 Table 44. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application (2017-2022) 42 Table 45. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (2017-2022) & (US$ Million) 42 Table 46. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Region (2017-2022) 43 Table 47. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 47 Table 48. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type (2017-2022) 48 Table 49. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 48 Table 50. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application (2017-2022) 48 Table 51. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) & (US$ Million) 48 Table 52. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Country (2017-2022) 49 Table 53. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type (2017-2022) & (US$ Million) 50 Table 54. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type (2017-2022) 51 Table 55. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application (2017-2022) & (US$ Million) 51 Table 56. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application (2017-2022) 51 Table 57. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country (2017-2022) & (US$ Million) 51 Table 58. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Country (2017-2022) 52 Table 59. Amgen Company Details 54 Table 60. Amgen Business Overview 54 Table 61. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product 55 Table 62. Amgen Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies Business (2017-2022) & (US$ Million) 56 Table 63. Amgen Recent Development 56 Table 64. Immunocore Company Details 57 Table 65. Immunocore Business Overview 58 Table 66. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product 58 Table 67. Immunocore Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies Business (2017-2022) & (US$ Million) 59 Table 68. Immunocore Recent Development 59 Table 69. Johnson & Johnson Company Details 60 Table 70. Johnson & Johnson Business Overview 60 Table 71. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product 61 Table 72. Johnson & Johnson Recent Development 62 Table 73. Roche Company Details 62 Table 74. Roche Business Overview 63 Table 75. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product 63 Table 76. Roche Recent Development 64 Table 77. Pfizer Company Details 65 Table 78. Pfizer Business Overview 65 Table 79. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product 66 Table 80. Pfizer Recent Development 66 Table 81. AbbVie Company Details 66 Table 82. AbbVie Business Overview 67 Table 83. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product 67 Table 84. AbbVie Recent Development 68 Table 85. MacroGenics Company Details 68 Table 86. MacroGenics Business Overview 69 Table 87. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product 69 Table 88. MacroGenics Recent Development 69 Table 89. Regeneron Company Details 70 Table 90. Regeneron Business Overview 70 Table 91. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product 70 Table 92. Regeneron Recent Development 71 Table 93. Astellas Pharma Company Details 71 Table 94. Astellas Pharma Business Overview 71 Table 95. Astellas Pharma Recent Development 72 Table 96. GEMoaB Monoclonals Company Details 72 Table 97. GEMoaB Monoclonals Business Overview 73 Table 98. GEMoaB Monoclonals Recent Development 73 Table 99. Molecular Partners Company Details 74 Table 100. Molecular Partners Business Overview 74 Table 101. Molecular Partners Recent Development 74 Table 102. AstraZeneca Company Details 75 Table 103. AstraZeneca Business Overview 75 Table 104. AstraZeneca Recent Development 76 Table 105. Merck Company Details 76 Table 106. Merck Business Overview 76 Table 107. Merck Recent Development 77 Table 108. Eli Lilly Company Details 77 Table 109. Eli Lilly Business Overview 78 Table 110. Eli Lilly Recent Development 78 Table 111. IGM Biosciences Company Details 79 Table 112. IGM Biosciences Business Overview 79 Table 113. IGM Biosciences Recent Development 80 Table 114. Novartis Company Details 80 Table 115. Novartis Business Overview 80 Table 116. Novartis Recent Development 81 Table 117. CytomX Therapeutics Company Details 81 Table 118. CytomX Therapeutics Business Overview 82 Table 119. CytomX Therapeutics Recent Development 82 Table 120. Lava Therapeutics Company Details 83 Table 121. Lava Therapeutics Business Overview 83 Table 122. Lava Therapeutics Recent Development 83 Table 123. Takeda Company Details 84 Table 124. Takeda Business Overview 84 Table 125. Takeda Recent Development 84 Table 126. Research Programs/Design for This Report 88 Table 127. Key Data Information from Secondary Sources 92 Table 128. Key Data Information from Primary Sources 93 List of Figures Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Picture 1 Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type: 2021 3 Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type: 2028 3 Figure 4. T Cell Engagers Features 4 Figure 5. NK Cell Engagers Features 5 Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application: 2021 6 Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application: 2028 6 Figure 8. T-Cell & NK-Cell Engaging Bispecific Antibodies Report Years Considered 8 Figure 9. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (US$ Million), Year-over-Year: 2017-2028 9 Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, (US$ Million), 2017 VS 2022 VS 2028 10 Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Regions: 2021 11 Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Regions: 2028 11 Figure 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Regions (2017-2028) 13 Figure 14. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share in Global Market 2017-2028 14 Figure 15. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Players in 2021 18 Figure 16. The Top 2 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2021 20 Figure 17. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 28 Figure 18. United States T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 30 Figure 19. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 31 Figure 20. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 32 Figure 21. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 33 Figure 22. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 36 Figure 23. France T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 37 Figure 24. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 38 Figure 25. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 39 Figure 26. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 40 Figure 27. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 41 Figure 28. China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 43 Figure 29. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 44 Figure 30. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 45 Figure 31. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 45 Figure 32. India T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 46 Figure 33. South America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 47 Figure 34. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 49 Figure 35. Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 50 Figure 36. Middle East T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 52 Figure 37. Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size YoY Growth (2017-2028) & (US$ Million) 53 Figure 38. Bottom-up and Top-down Approaches for This Report 90 Figure 39. Data Triangulation 91 Figure 40. Key Executives Interviewed 93
Market Analysis and Insights: Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market This report focuses on global and Japan T-Cell & NK-Cell Engaging Bispecific Antibodies market.
In 2021, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size was US$ 472 million and it is expected to reach US$ 5072 million by the end of 2028, with a CAGR of 40.82% during 2021-2028. In Japan the T-Cell & NK-Cell Engaging Bispecific Antibodies market size is expected to grow from US$ 1.88 million in 2021 to US$ 173.15 million by 2028, at a CAGR of 99.82% during the forecast period. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Scope and Market Size T-Cell & NK-Cell Engaging Bispecific Antibodies market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global T-Cell & NK-Cell Engaging Bispecific Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2017-2028. By Company Amgen Immunocore Johnson & Johnson Roche Company Five AbbVie MacroGenics Regeneron Astellas Pharma GEMoaB Monoclonals Molecular Partners AstraZeneca Merck Eli Lilly IGM Biosciences Novartis CytomX Therapeutics Lava Therapeutics Takeda Segment by Type T Cell Engagers NK Cell Engagers Segment by Application Hematological Cancers Solid Tumors By Region North America United States Canada Mexico Asia-Pacific China Japan South Korea Southeast Asia Australia India Rest of Asia Europe Germany France U.K. Italy Russia Rest of Europe South America Brazil Rest of South America Middle East & Africa Middle East Africa
CHOOSE LICENSE TYPE
USD 3900.00
USD 5850.00
USD 7800.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
-
Fastest report delivery service
-
More than 17 years of vast experience
-
Operation for 24 * 7 & 365 days
-
In-depth and comprehensive analysis
-
Professional and timely after-sales service
-
Owns large database
Add to Cart
Buy Now